
Home » FDA Highlights Biocompatibility Concerns Over NuVasive’s Precice Devices
FDA Highlights Biocompatibility Concerns Over NuVasive’s Precice Devices

The FDA has issued an alert to healthcare providers over potential biocompatibility concerns related to NuVasive Specialized Orthopedics’ Precice devices.
The products listed in the alert are the Precice Bone Transport, Precice Plate and Precice Stryde, which are made of stainless steel, and the Precice Freedom, Precice Intra-medullary Limb Lengthening Device, Precice Short and Precice Unyte, which are based on titanium.
The FDA said it has received “reports of pain and changes in the surrounding bone and soft tissue in people implanted with the Precice Stryde device.”
Upcoming Events
-
07Dec
-
13Dec
-
14Apr